CBDS - Cannabis Sativa, Inc.
| Previous Close | 1.5500 |
| Open | 1.5700 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.4100 - 1.6250 |
| 52 Week Range | 1.4100 - 8.5000 |
| Volume | 64,522 |
| Avg. Volume | 72,315 |
| Market Cap | 32.701M |
| Beta (3Y Monthly) | 0.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1830 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE•24 days ago
Cannabis Sativa Enters into Letter of Intent to Acquire Lacuna Botanicals CBD Company
MESQUITE, NV / ACCESSWIRE / June 3, 2019 / Cannabis Sativa, Inc. (CBDS) is proud to announce a signed Letter of Intent to acquire Lacuna Botanicals, a premier Colorado based CBD product line with manufacturing and distribution. "Lacuna Botanicals https://lacunabotanicals.com/ offers products designed to relax, rejuvenate and restore," said founder Jeremiah Molfese. Lacuna Botanicals bioactive creams, elixirs, oils and pet care products incorporate a wide range of botanical ingredients including terpenes, essential oils and Cannabinoids such as CBD.
- InvestorPlace•27 days ago
4 Best Marijuana ETFs for Conservative Portfolios
Editor's note: This story was previously published in February 2019. It has since been updated and republished.Investors are clamoring for ways to get in on a popular, but risky, marijuana-investing craze. Despite the reality that pot is illegal under federal law, many states have legalized the substance and plenty of marijuana ETFs have cropped up as a result.For recreational use, Oregon, Massachusetts, California and a few more states allow marijuana use. Yet, the majority of U.S. states have medical marijuana legislation in the pipeline. Presently, with the legal disconnect between federal and state law regarding marijuana use, investing directly in U.S. marijuana ETFs and stocks is risky and replete with scams and fraud.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks to Buy for Monster Growth If you're determined to get in on the marijuana investing scene, there are several conservative-ish marijuana ETFs for partaking in the speculative pot party: Alternative Harvest ETF (MJ)Hot off the New York Stock Exchange, the Alternative Harvest ETF (NYSEARCA:MJ) began trading on Dec. 26, 2017.Source: Shutterstock Derived from an international real estate investment trust (REIT) fund, the marijuana ETF tracks cannabis cultivators, producers and distributors, along with cannabinoid drug makers, fertilizer producers and tobacco companies.As the first of what is sure to be many U.S. marijuana ETFs, the Alternative Harvest enjoys a first-mover advantage. American Growth Fund (AMREX)It's risky to call American Growth Funds Series Two Class E (MUTF:AMREX) a conservative marijuana pick., as the fund has racked up significant losses in the pastSource: Shutterstock Yet, if you're a contrarian seeking a fund with access to the cannabis industry through marijuana ETFs you might consider AMREX.AMREX's top holdings include some well-known names and other niche pot players including GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH), Scotts Miracle-Gro Co (NYSE:SMG), Abbott Laboratories (NYSE:ABT), Cara Therapeutics Inc (NASDAQ:CARA), Cannabis Sativa Inc (OTCMKTS:CBDS) and more. * 7 Stocks to Sell Amid an Escalating Trade War The fund is small and hasn't gained serious investor traction, but it might be a good diversifier against the movements of the S&P 500. Cronos Group Inc. (CRON)Go north for another fund tapping into marijuana ETFs. Cronos Group (NASDAQ:CRON), formerly known as PharmaCan Capital Corp, and formerly trading on the OTC market under "PRMCF," is an investment firm focused on investing in the medical marijuana industry.Source: Shutterstock Cronos' investments abide by Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). Founded in 2013 in Toronto, the fund targets Canadian firms and makes minority investments in cannabis-related firms. Create Your Own Pot Mutual FundDiversification is key when investing in a speculative sphere like marijuana ETFs. You might want to dip your toes in the above marijuana ETFs and add in some popular cannabis-related stocks to round out your pot portfolio.Source: Shutterstock M1 Finance and Motif both allow you to create your own mutual fund, for extremely low fees. You can choose the investments, purchase your preferred amount and voila, you have your own marijuana ETF, comprised of both funds and individual stocks!In addition to the funds profiled above, consider adding several pure marijuana industry stocks and pot-related holdings. Top marijuana stocks include Canopy Growth, Aphria Inc (NYSE:APHA) and GW Pharmaceuticals. Peripherally related pot stocks include Scotts Miracle-Gro or Constellation Brands, Inc. (NYSE:STZ). * 7 Stocks That Won Super Bowl Sunday Investing in marijuana is risky. With the disconnect between state and federal marijuana laws, putting your money in this sector sets you up for a roller coaster ride. Tread cautiously into the pot investing fields.Barbara A. Friedberg, MBA, MS is a veteran portfolio manager, expert investor, and former university finance instructor. She is editor/author of Personal Finance; An Encyclopedia of Modern Money Management and two additional money books. She is CEO of Robo-Advisor Pros.com, a robo-advisor review and information website. Additionally, Friedberg is publisher of the well-regarded investment website Barbara Friedberg Personal Finance.com. Follow her on twitter @barbfriedberg and @roboadvisorpros. As of this writing, she does not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 F-Rated Stocks That Could Break Your Portfolio * 5 Fintech Stocks to Buy As This Mega Trend Gains Steam * 10 Cold Weather Stocks to Heat Up Your Returns Compare Brokers The post 4 Best Marijuana ETFs for Conservative Portfolios appeared first on InvestorPlace.
- InvestorPlace•last month
6 Marijuana Stocks With Critical Levels to Watch
In financial markets, there are certain price levels that are more significant than others with regard to the amount of supply and demand that exists at them. In addition, prices are always doing one of three things. They are either going up, going down or going nowhere. When understood and applied correctly, technical analysis is an illustration of these dynamics. Being aware of, and understanding where these levels and trends are when investing in marijuana stocks can lead to massive profits.Yes, technical analysts get a bad rap and I can understand why. Most technical analysts do not seem to understand the fundamentals. To make matters worse, some analysts employ esoteric techniques, such as Gann Theory, Harmonic Patterns or Elliot Waves. In my opinion there is no validity to such methods. They are in the realm of the Bigfoot and UFOs … fun to talk about, but hardly credible. Professional institutional traders do not pay attention to them.As someone who traded in the hedge fund world for more than twenty years, I can tell you first hand what the pros do care about: Important support and resistance levels, trends, momentum, and risk management.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Names That Are Screaming Stocks to Buy Let's take a look and some of the supply-and-demand dynamics that are occurring in marijuana stocks. Knowing where the important levels and trends are can help you develop trading ideas. It can also and help you decide at which levels to place your buy and sell orders, and whether you should use market or limit orders. Read on for advice on how and where to trade the most popular pot stocks in the market today: Marijuana Stocks to Buy 2019: Aphria (APHA) Click to Enlarge Aphria (NYSE:APHA) grows and sells marijuana. In additional to cannabis, their products include things like capsules and vaporizers.On Monday the company announced that its President Jakob Ripshtein resigned. There has been considerable employee turnover in the upper echelons of management recently at Aphria. In January, CEO Vic Neufeld and Co-founder Cole Cacciavillani announced their resignation. Time will tell if these changes are a good or bad thing.The APHA stock price has fallen about 30% in the past month, but it just broke its downtrend after becoming oversold.It has been consolidating around the $7 level. In this situation, if I had been waiting to buy, I would go ahead and pull the trigger. This is because the downtrend line has been broken, possibly due to the sellers decision to cancel their orders on account of Ripshtein's resignation.There is nothing mysterious about trendlines -- they are really just logic and common sense. If used correctly, trendlines should simply be graphical representations of the supply and demand dynamics that are occurring in markets. When the trend was headed lower it meant that the forces of supply were in control. Now that the downtrend has been broken, it illustrates that the forces of demand have equalized with the forces of supply. Canopy Growth (CGC) Click to Enlarge Canopy Growth (NYSE:CGC) is also a producer and distributer of marijuana. In terms of market capitalization, it is the largest Cannabis company in the world.You don't need to be a market guru to see that the levels between $65 and $70 have been an area of resistance. Since last September every time CGC traded up to these levels, the forces of supply stepped in and drove it down.An important thing to understand about this company is that it loses money and CGC seems to be headed in the wrong direction. Last year the loss was 40 cents per share. That's nearly three times greater than the loss of 14 cents in 2017. In 2016, the loss was 5 cents per share. * 10 Small-Cap Stocks That Look Like Bargains This is a situation where, if I was considering selling, I would pull the trigger. If I was a buyer I would wait. The reasons are simple: Canopy stock is starting to trend lower and there is resistance just overhead. The path of least resistance seems to be to the downside. Aurora Cannabis (ACB) Click to Enlarge Aurora Cannabis (NYSE:ACB) sells a lot of weed. ACB just reported its last quarter's earnings and its gross margins came in at a hefty 55%. Further, revenue grew 20% to 65 million CAD, or roughly $50 million U.S. dollars. That works out to be about nine tons of the green stuff!It is clear that over the past eighteen months, the $14 level has been where the sellers come alive. It was the top in early 2018, again in September, and, most recently, in April. If you are planning on selling Aurora Cannabis stock, knowing this level is important.For example, suppose your broker or friend told you that ACB stock was worth $15 per share, suggesting you place your sell order at that level. The fact that there is a lot of supply at the $14 level may prevent the stock from getting to $15. It may make a better decision to place the order at $14. Sure, it is a lower price but it is probably better than having your order at $15 not be executed because the stock once again got to $14 and then proceeded to head lower.It is currently oversold and testing support around the $10.30 level. There is support there because it was resistance in November and January. Cronos Group (CRON) Click to Enlarge Cronos Group (NASDAQ:CRON) produces and sells cannabis in Canada and Germany. You don't need to be a master trader to see that the $14 level is important to the CRON stock price. This level acted as resistance for Cronos stock in September and December, and now it is providing support.Support levels form when a stock trades at a certain level and vested interest develops. In September and December, some investors sold short their CRON stock at $14. For a while, they were happy because they were thinking that they would be taking some profits. But in January, CRON traded above that.The short sellers are now underwater and looking at taking losses. They tell themselves that if the stock trades back down to $14, they would close out their trades and break even. This means that now there will be buy interest and the $14 level will become support.This is a situation where I would act whether I was a buyer or a seller. That is because it is either going to break support and fall or rebound and rise. One thing is for certain: It won't stay at $14 forever. * 10 Baby Boomer Stocks to Buy You have to make a decision to act whether you are bullish or bearish. If you are correct and you wait too long, you may miss out on some profits. Cannabis Sativa (CBDS) Click to Enlarge Cannabis Sativa, Inc (OTCMKTS:CBDS) is engaged in all types of business related to cannabis, They develop, acquire and license various products including edibles, recipes and delivery systems. Maybe they do too many things because the company has been losing money for years. Over the past five years it has lost about $40 million.CBDS stock has found support at prior support levels, though. This illustrates the importance of being aware of where the previous lows are. If you were considering buying CBDS shares and realized that it was in a downtrend and approaching levels that had been support in the past, then it would make sense to wait for a better price.Recently, Cannabis Sativa stock has broken its downtrend and is consolidating. That means that the forces of supply have become equal with the forces of demand. While it was trending lower the forces of supply were in control. Now the forces of supply and demand have become equalized. This is what traders call sideways trading. Horizons Marijuana Life Sciences ETF (HMLSF) Click to Enlarge Horizons Marijuana Life Sciences ETF (OTCMKS:HMLSF) is a popular exchange-traded fund (ETF). You can see that it is testing support around the $15 level. This level was support on April 15. It is important because it was resistance in March and June of last year. It is also important psychologically.Why is there support at this level? One reason is because there were investors who were considering buying it in April but never entered the trade. When they missed it, they told themselves that if it ever got back to $15, they would buy it. These dynamics form support.This is one of the reasons why professional traders pay attention when stocks are approaching levels that were recent tops or bottoms. They understand these dynamics and use them to profit. * 7 Stocks to Buy that Lost 10% Last Week The long-term importance of the $20 level is obvious. It was resistance at the beginning of last year and again in September and October. This would be a logical area to place a Good-Til-Cancelled (GTC) sell order.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 6 Stocks to Buy for This Decade's Massive Megatrend * The 7 Best Stocks to Buy From the IPO ETF * 7 Athletic Apparel Stocks With Marathon Pace Compare Brokers The post 6 Marijuana Stocks With Critical Levels to Watch appeared first on InvestorPlace.
- InvestorPlace•last month
This Cannabis Company Will Probably End Up in the Dustbin of Wall Street History
Like many marijuana stocks, this pot company loses money and is probably destined for the dustbin of Wall Street history, but it may be setting up for a low-risk, high-reward short term investment. Cannabis Sativa, Inc. (OTCMKTS:CBDS) is involved in many areas of the cannabis industry. There are definitely some lessons to be learned from a situation like this, Here are five things to consider:Source: Shutterstock Radar Screen: This stock got on to my radar screen because it is in the cannabis industry. it has also dropped 70% since September. Anytime that a stock falls that dramatically in such a short period of time, there is always a chance of a rebound or a 'dead cat bounce'.Fundamentals: The company has been losing money for years. Last year's loss was (.20) per share.InvestorPlace - Stock Market News, Stock Advice & Trading TipsTechnicals: The stock is oversold and at levels that were support in the past. The $2 level was support last September, and after the recent selloff it has become support again. In addition, it has been in a clear downtrend . Because it is oversold and at support, there is a significant chance that it could rebound off of these levels. If it does, it seems like the next important resistance level is around $2.70. This level was support in December.Risk Management: We need to understand that humans have not evolved in a way that is conducive for successful trading or investing. When money is on the line it incites an emotional response. Fear of taking a loss makes investors hold on to losers for too long. Fear of missing a profit causes investors to close out their winners too early. That is why you should never enter a position unless you know where you will take your stop-out loss and where you will take profits. This is the most important rule of investing! Click to Enlarge Here is what I would do. The trigger to enter the trade would be the break of the downtrend line. My stop-out would be at $1.95 and my sell price is $2.65. The sell price for taking a profit is just below a level that will probably be resistance.The sell price for taking a loss is just below important support. That is because if the support breaks, the stock could trend much lower.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Stocks to Sell Before They Tank Your Portfolio * Top 7 Dow Jones Stocks of 2019 -- So Far * 5 Low-Priced, High-Potential Tech Stocks to Buy Compare Brokers The post This Cannabis Company Will Probably End Up in the Dustbin of Wall Street History appeared first on InvestorPlace.
- InvestorPlace•2 months ago
7 Marijuana Stocks That Are Bleeding Cash
You may find it surprising, but the Post Office, the Atlanta Hawks and these seven marijuana stocks all have something in common. At first glance, you may think they have nothing to do with each other. After all, the Post Office is run by the government, the Atlanta Hawks are a professional basketball team and cannabis companies were established to profit off of the booming legal cannabis industry.But unfortunately, these very different organizations do in fact have something in common. And it just so happens that it is a very important thing. They are all losing money! None of them have made a profit in years!Obviously, the Post Office can continue to lose money forever because it's run by the governmental and the government can just raise taxes. And a professional sports team can continue to lose money as long as the owners are willing to sustain the losses.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBut let's talk about the cannabis companies In the stock market, the idea is to invest in companies that are, or will be, profitable. This profitability will, in turn, lead to the share price appreciating. Financial theory, history and common sense all tell us that if a company doesn't make money it will eventually go out of business. Investors will see declining share prices and losses.Looking at the Cannabis Companies: You are probably familiar with the following companies if you trade or invest in the cannabis markets. They may have cool products and be in a cool industry, but if you are considering investing in them, it is important to understand that they are losing money. You may ask yourself, "how have they been able to lose money for a sustained period of time?"The answer is that they borrow money or issue stock and use these proceeds to cover their expenses. But eventually, the ability to do so will stop if they are never able to turn a profit. * 7 Strong Buy Stocks That Tick All the Boxes I am not saying that these companies will never earn money and that you can't profit by investing in their stocks. Some of them may eventually become great investments. My intent here is to express my belief that before making an investment in a company, one should consider if it is actually making money and what the future prospects of profitability are. In the long run, these dynamics will ultimately have a significant effect on the share price. Axim Biotechnologies (AXIM) Click to Enlarge Axim Biotechnologies (OTCMKTS:AXIM) makes a really cool product. It is a biotechnology company based in New York City. The company makes chewing gum that is infused with medicinal cannabis. This is used to treat pain, anxiety and other conditions. It can even be used to treat opioid addiction, which we all know is a terrible epidemic. I am not really sure how they do it because I'm a stock market guy, not a scientist, but I think it sounds like an awesome idea.But let's take a look at some numbers. Last year AXIM lost 12 cents per share. That means that for the year the company lost about $6.7 million. Unfortunately, losing money is nothing new to this company. In 2017 they lost $4.2 million, in 2016 the loss was $7.3 million, and it 2015 it was just over $10 million.Not surprisingly, the stock has not acted well. It is currently trading around the $1.50 level. As you can see on the chart, over the past year it has lost about 70% of its value. Maybe someday one of the company's product will be a huge success and it will become profitable, but over the past few years, it has certainly been a disappointment to shareholders. Americann (ACAN) Click to Enlarge Americann, Inc. (OTCMKTS:ACAN) is next on the list. Like many other cannabis companies, they are based in Denver. This company develops medical cannabis cultivation and processing properties. In other words, they build greenhouses. The greenhouses they build aren't like the kind my grandfather had in his garden. These are big-time greenhouses that are used for largescale industrial growing. They have built and developed over one million square feet of growing area.Americann has been involved with some enormous projects. Some of the projects include the Denver Medical Cannabis Center, the Massachusetts Medical Cannabis Center and the Illinois Medical Cannabis Center. The company is also committed to sustainability and uses clean energy from solar and geothermal sources. * 7 Stocks to Buy From the T. Rowe Price Health Sciences Fund Apparently, the Cannabis greenhouse business isn't very profitable -- at least in the way that Americann does it. Last year they lost $4.4 million which equates to a loss of 22 cents per share. This is more than they lost in the prior few years. In 2017 the loss was $2.7 million, in 2016 it was $2.2 million, and in 2015 the loss was $1.7 million. Maybe one day the company will be profitable but, as for now, they seem to be headed in the wrong direction. General Cannabis Corp. (CANN) Click to Enlarge General Cannabis Corp. (OTCMKTS:CANN) is a holding company that is based in Denver. They have four different segments -- security, operations, consumer goods and investments.The security segment provides different types of services to cannabis growers and retails stores. These services include video surveillance, transporting cash and providing security professionals. Consulting services to the cannabis industry that include obtaining licenses, compliance, logistics, retail operations and facility services are offered by the operations segment. The consumer goods segment includes developing relationships with apparel retailers and distributors. The investments segment provides loans and financing to companies within the cannabis industry.General cannabis is clearly an organization that is involved in many things. Maybe it is involved in too many things. Have you ever heard the expression "jack of all trades and master of none?" I think that could apply here. This company hasn't earned any money in years. Last year it lost almost $17 million, or 49 cents per share. The prior year's losses were less than half of that. In 2017, the loss was just over $8 million. In 2016, General cannabis lost just over $10 million and, in 2015, the loss was almost $9 million. If you're keeping track, this company has lost a total of $44 million in the past four years. Cannabis Sativa (CBDS) Click to Enlarge Cannabis Sativa, Inc. (OTCMKTS:CBDS) is next up on the list of losers. After looking at the company website for a while, I couldn't even figure out just what they actually do. I think it has something to do with providing services to cannabis dispensaries. Here is the description from MarketWatch:"Cannabis Sativa, Inc. engages in the research, development, acquisition and licensing of specialized natural cannabis related products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. The company was founded on November 5, 2005 and is headquartered in Mesquite, NV."This company seems very mysterious to me. According to MarketWatch, there is only one employee despite having revenues that were over $500 million. One of the things that I noticed when I was looking at the financials is that the Quick Ratio is only 0.25 while the average Quick Ratio for the industry is 2.67.The Quick Ratio is the company's cash and short-term securities divided by the current liabilities. Current typically means one year or less. In other words, Cannabis Sativa only has 25 cents for each dollar of debt that they have, while the industry average is to have $2.61 for each $1 of debt. With a ratio like that, it isn't surprising that they are losing money. * 7 Energy Stocks to Buy to Light Up Your Portfolio The losses were $4.1 million in 2018, $7.6 million in 2017, $3.1 million in 2016, and $9.4 million in 2015. Tilray (TLRY) Click to Enlarge Tilray Inc. (NASDAQ:TLRY) hasn't been a publicly traded company for that long. The initial public offering was last summer. This company has the distinction of being the first publicly traded cannabis company to list on the Nasdaq. Their business model is very understandable. They engage in research, cultivation, production, and distribution of cannabis and cannabinoids. Products include dried cannabis and cannabis extracts. In other words, they grow and sell weed.Like the others, this company is losing money as well. I have heard that the cannabis markets are glutted and that the price of cannabis has fallen dramatically since its legalization. Many cannabis farmers are losing a lot of money. Maybe that is why Tilray is losing money as well.Tilray went public last year, but they have disclosed financial information going back further. If you think about it, it is kind of amazing that a company that loses money could go public. This was a common occurrence back in the dot-com era. The company has a market capitalization of around $5 billion despite the fact that they lost $67 million last year. In 2017, they lost about $8 million and had a similar size loss in 2016. 22nd Century Group (XXII) Click to Enlarge 22nd Century Group, Inc. (OTCMKTS:XXII) is based in Clarence, New York. It is a biotech company. They research and develop technologies that will allow the increase or decrease of the levels of nicotine and nicotinic alkaloids in tobacco plants and the levels of cannabinoids in cannabis plants. My guess is that there will be greater demand for increasing than decreasing. This is done through genetic engineering and plant breeding. Sounds like pretty neat stuff.But don't let their cool name and cool stock symbol fool you. They are losing money. Last year the loss was $10.4 million. That is a loss of 8 cents per share. In 2017, the annual loss was close to $17 million. The loss in 2016 was just over $15 million and the loss in 2015 was just over $14 million. * 7 Stocks Worth Buying When They're Down Maybe this company will turn around one day and become successful, but the current shareholders must be disappointed. The valuation has fallen by about one-third since December as the price per share has fallen from $3 to $2 while the broader equity markets have been booming since then. The Supreme Cannabis Co (SPRWF) Click to Enlarge The Supreme Cannabis Co, Inc. (OTCMKTS:SPRWF) is last on the list. Obviously, there are many other cannabis companies that are losing money out there, but today I just wanted to focus on these seven because they seem to be popular recently. Supreme has a similar business model as Tilray. The company grows and sells cannabis, although the product may be a little different because they say it is '"sun-grown." I suppose this is in contrast to being grown with artificial light. Supreme does this through their wholly owned subsidiary 7ACRES.Perhaps The Supreme Cannabis Company should consider changing their name to "The Subprime Cannabis Company" because it is losing money. It has seen the price of its stock fall by about 20% since September. Last year the company lost around $7.3 million. Losses in 2017 were more than twice that at $15.3 million. The loss in 2016 was $4.4 million and the loss in 2015 was about $5.7 million. Maybe the future will be better, but my guess is that The Supreme Cannabis Company's shareholders are supremely disappointed.As of this writing, Mark Putrino did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Energy Stocks to Buy to Light Up Your Portfolio * 10 Vice Stocks to Spice Up Your Portfolio * 7 of the Best ETFs to Buy for a Slowing Economy Compare Brokers The post 7 Marijuana Stocks That Are Bleeding Cash appeared first on InvestorPlace.
- ACCESSWIRE•2 months ago
PrestoDoctor, Leading Telemedicine Provider of Medical Marijuana Evaluations, Expands Services to Oklahoma
MESQUITE, NV/ ACCESSWIRE / April 17, 2019 / Cannabis Sativa, Inc. (OTCQB:CBDS) is proud to announce that PrestoDoctor has expanded its telemedicine services into Oklahoma. Currently, PrestoDoctor provides cannabis patients with medical marijuana recommendations via both their online telemedicine platform and dispensary kiosks operating in California, Nevada, and New York, and will now extend their services into Oklahoma. ''PrestoDoctor offers a fast, confidential and cost-effective way for patients to become authorized medicinal marijuana users'', stated COO Rob Tankson.
- ACCESSWIRE•3 months ago
Cannabis Sativa 2018 Update and 2019 Outlook
MESQUITE, NV / ACCESSWIRE / April 10, 2019 / Cannabis Sativa, Inc. (OTCQB: CBDS) reports that the Company has been busy in 2018 laying the groundwork for future growth in the cannabis arena. While the Company revenue and margins grew 58% and 80%, respectively, during 2018, the $506k revenue number was far short of management's goal. CBDS' growth initiatives are focused on investments in, and partnerships with, revenue-generating, cannabis-related businesses that have management in place and are expected to be accretive within one year.
- ACCESSWIRE•3 months ago
Debby Goldsberry to Speak at Cannabis Conference Las Vegas
MESQUITE, NV / ACCESSWIRE / March 29, 2019 / Cannabis Sativa, Inc. (OTCQB: CBDS) is proud to announce that Independent Director Debby Goldsberry will be speaking at Cannabis Conference, in Las Vegas, NV., ...
- ACCESSWIRE•5 months ago
PrestoDoctor's Rob Tankson Featured Guest at New York Fashion Week's FASHINNOVATIO
MESQUITE, NV / ACCESSWIRE / February 4, 2019/ Cannabis Sativa, Inc. (OTCQB: CBDS) is proud to announce that PrestoDoctor founder Rob Tankson will be a featured guest at FASHINNOVATION, a platform where fashion and technology connect with a mission to inspire and share knowledge in the fashion, entrepreneurship and technology sectors, is hosting the second edition of its semi-annual conference on February 13, 2019. The all-day red carpet event takes place during NYFW at one of the city's premiere venues, Tribeca Rooftop, and features panels, live performances, installations, displays, and aims to "humanize homelessness" with the launch of a book titled: It Can Be You by The NYLON Project.
- ACCESSWIRE•5 months ago
Virgin Mary Jane to Exhibit at LA Cannabis Wedding Expo
MESQUITE, NV / ACCESSWIRE / January 25, 2019 / Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce that Virgin Mary Jane Brand http://virginmaryjanebrand.com will be among the most innovative companies ...
- GlobeNewswire•6 months ago
Breaking News: Congress Passes 2018 Farm Bill; Lots of Green Potential to Gain Big in this Uncertain Market
While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With Congress approving the 2018 Farm Bill, stocks in the CBD space are poised to benefit and should run counter to the current market downward trends. The passage of the 2018 Farm Bill presents a tremendous opportunity for the CBD sector to continue to grow while the rest of the market shows significant volatility. Cannabidiol, or CBD, is the non-psychoactive chemical compound found in the hemp plant.
- GlobeNewswire•7 months ago
Ready, Set, Grow – A New Era with 2018 Farm Bill; Cronos Group Inc., Canopy Growth Corporation, Tilray, Inc., Cannabis Sativa, Inc., American Premium Water Corporation
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing opportunity in the sector with the expected imminent passing of the US 2018 Farm Bill. Cabot Wealth said last week in an article, What the Farm Bill Means for Cannabis Stocks, “If the Farm Bill passes with hemp legalization intact, it could herald boom times for the CBD industry, with giant retail players like Walgreens and CVS and Walmart becoming the biggest retailers.
- GlobeNewswire•7 months ago
Breaking News: Expected Passage of 2018 Farm Bill on Monday Could Provide Opportunity to Gain Big in this Uncertain Market
While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With the expected vote and passage of the 2018 Farm Bill on Monday, stocks that are in the CBD space are poised to benefit and should run counter to the current market downward trends. Stocks in the CBD and cannabis space have not been immune from the market’s downturn, but the expected passage of the bill should provide an opportunity to acquire high growth stocks in this bear market. The 2018 Farm Bill will nationally legalize the cultivation and farming of that plant.
- ACCESSWIRE•8 months ago
Cannabis Lozenge Patent Issued to Cannabis Sativa, Inc. by Us Patent & Trademark Office
MESQUITE, NV / ACCESSWIRE / October 25, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that on October 23, 2018, the United States Patent Office issued US Patent number 10105343 titled “Cannabis based compositions and methods of treating hypertension” to Cannabis Sativa”. The marijuana lozenge invention relates to a Cannabis-based pharmaceutical composition for the treatment of hypertensive disorders by submucosal delivery comprising a pharmaceutically acceptable base and an effective amount of at least one cannabinoid or endocannabinoid containing extract of a cloned hybrid of the plant Cannabis sativa, subspecies sativa and Cannabis sativa, subspecies indica of the CTSX-ISS lineage. “CBDS acquired the rights to certain pending IP in a stock based, multimillion dollar agreement in 2014”, said President David Tobias.
- InvestorPlace•8 months ago
9 Marijuana Stocks to Play the Pot Craze
Marijuana stocks, fueled by what may well be the biggest legal and medical revolution in years, have already proven they’re blazing their own trail. In all cases, though, there’s explosive potential on the table — the legal marijuana industry’s story has just gotten that compelling, as more states seek to legalize it while regulators finally start to see its legitimate medical benefits. Of all the marijuana stocks worth a look right now, Canopy Growth (NYSE:CGC) has garnered the most attention of late.
- ACCESSWIRE•8 months ago
Marijuana Lozenge Patented by Cannabis Sativa
MESQUITE, NV / ACCESSWIRE / October 15, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that the United States Patent Office will issue to CBDS the US Patent number 10105343 titled "Cannabis based compositions and methods of treating hypertension" on October 23, 2018. "Cannabis Sativa made a bold deal acquiring this pending IP in the merger acquisition of Kush in 2014, which included Kubby Patent and Licenses. "This coconut oil based lozenge is unique because of its rapid onset and long term effects, and is based on our patented strain of cannabis, Ecuadorian Sativa", stated President David Tobias.
- ACCESSWIRE•9 months ago
Top Rated Telemedicine Firm PrestoDoctor Launches Online Medical Marijuana Recommendation Portal in Pennsylvania
MESQUITE, NV / ACCESSWIRE / September 25, 2018 / Cannabis Sativa, Inc. (CBDS) subsidiary PrestoDoctor is pleased to announce that it is currently providing online medical marijuana recommendations to Pennsylvania residents via its HIPPA compliant trusted online recommendation platform https://Prestodoctor.Com/. PrestoDoctor makes the process simple and seamless by providing the state required two doctor appointments completely online, allowing patients to speak to licensed compassionate physicians who specialize in medical marijuana evaluations. Post appointment, PrestoDoctor provides patients all the necessary instructions on registering with the state in a comprehensive email.
- ACCESSWIRE•9 months ago
Today's Research Reports on Trending Tickers: Aurora Cannabis and Cannabis Sativa
NEW YORK, NY / ACCESSWIRE / September 18, 2018 / U.S. equities retreated from records Monday as President Donald Trump plans to announce an additional $200 billion in tariffs on Chinese products. The Dow ...
- InvestorPlace•9 months ago
If Past Is Prologue, It’s Time to Dump Tilray Stock While You Still Can
Tilray (NASDAQ:TLRY) has made some lucky investors much, much richer than they were just a few weeks ago. Tilray stock is now up more than 500% from its July 19 IPO price, and up more than 350% for traders who bought it on the open market immediately following its initial public offering.
- ACCESSWIRE•9 months ago
Debby Goldsberry Tops High Times List of Women in Weed
MESQUITE, NV / ACCESSWIRE / September 12, 2018 / Cannabis Sativa, Inc. (CBDS) is pleased to announce that Debby Goldsberry, a member of the Cannabis Sativa Board of Directors, tops the High Times list of their first ever 'Women in Weed'' themed issue. Debby Goldsberry was lauded as an advocate and owner operator of Magnolia Oakland Dispensary. ''We congratulate Debby Goldsberry for her well-deserved top placement,'' said CEO and former Senator Mike Gravel, ''I am proud to have motivated Debby to come aboard Cannabis Sativa.
